Reproductive Tourism: Paying Women in Poor Countries to Bear Our Babies is Rife with Ethical Problems
By HealthCanal,
HealthCanal.com
| 10. 23. 2012
By some accounts, the Indian ART industry is worth $500 million to $2.3 billion.
In their upcoming paper, “Ethical concerns for maternal surrogacy and reproductive tourism” in the Journal of Medical Ethics, Professor Raywat Deonandan of the Interdisciplinary School of Health Sciences at the University of Ottawa, along with students Samantha Green and Amanda van Beinum, enumerate the specific ethical challenges posed by this emerging new industry.
Along with six other concerning issues, the authors identified the tension between business ethics and medical ethics as being at the heart of the industry’s ethical problem, along with an insufficiently broad definition of “informed consent.” When desperately poor, illiterate and vulnerable village women are entering into complicated contracts to sell their reproductive health to wealthy foreigners, often some of the softer social risks are not communicated to them, such as their risk of estrangement from their communities, or the risk of domestic unease with their spouses and existing children.
Part of the problem is that when commerce collides with medicine, there isn’t an agreed upon ethical framework for establishing rights and...
Related Articles
By Shivam Jadaun and Shivani, JURISTnews | 06.27.2024
Image by European Council from Flickr
In some European Union nations, the forced sterilisation of people with disabilities is still a widespread and concerning practice that blatantly violates their fundamental rights and human dignity. The scope of forced sterilisation in...
By Miri (Margaret) Raven, Alana Gall, Bibi Barba, and Daniel Robinson, The Conversation | 06.02.2024
Image by Ahmet Kurt from Unsplash
Last week, at a conference in Geneva, the member states of the World Intellectual Property Organisation agreed on a new treaty aimed at preventing the for-profit piracy of traditional knowledge.
So-called “biopiracy”, in...
By Osagie K. Obasogie, L.A. Review of Books | 04.17.2024
When Robert G. Edwards won the Nobel Prize in Physiology or Medicine in 2010 for developing in vitro fertilization (IVF) decades earlier in 1978, many members of the scientific community sighed in relief. This honor, they felt, was long...
By Ryan Cross, Endpoints News | 05.08.2024
A half-decade after a scientist’s reckless experiment with human embryos put a stop to much of China’s clinical work on CRISPR gene editing, local researchers are once again performing human studies of the technology.
At least three Chinese biotech companies...